Alternative opioids to morphine in palliative care: A review of current practice and evidence

Postgraduate Medical Journal

Volumn 77, Issue 908, 2001, Pages 371-378

  Barnett, M ^a,b  

^a WALSGRAVE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE; DEXTROMORAMIDE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIHYDROCODEINE; DIPIPANONE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE DERIVATIVE; OPIATE; OPIATE RECEPTOR; OXYCODONE; PENTAZOCINE; PETHIDINE; PHENAZOCINE; TRAMADOL;

CANCER PAIN; CONSTIPATION; DRUG ABSORPTION; DRUG ADMINISTRATION; HUMAN; MEDICAL DECISION MAKING; NAUSEA; NEUROPATHY; NOCICEPTION; PALLIATIVE THERAPY; PATIENT COMPLIANCE; QUALITY OF LIFE; REVIEW; SEDATION; UNITED KINGDOM;

ANALGESICS, OPIOID; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE;

EID: 0034984907     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.908.371     Document Type: Review

References (35)

1. The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report
2. Prescribing for the elderly
3. Individual variability in the response to different opioids: Report of tive cases
4. Doctor as murderer [editorial]
5. The Shipman inquiry: Implications for the public's trust in doctors [editorial]
6. Hydromorphone
7. Opioid rotation for toxicity reduction in terminal cancer patients
8. Decreased opioid doses used on a palliative care unit
9. Opioid rotation for cancer pain: Rationale and clinical aspects
10. The use of methadone in the care of the dying
11. Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics
12. Methadone: Outpatient titration and monitoring strategies in cancer patients
13. Subcutaneous methadone in terminally ill patients: Manageable local toxicity
14. The use of methadone in cancer pain poorly responsive to other opioids
15. Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double-blind, controlled trial
16. High-dose tramadol in comparison to low-dose morphine for cancer pain relief
17. Oral tramadol, a mu-opioid agonist and monamine reuptake-blocker, and morphine for strong cancer-related pain
18. Anenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone
19. Dose-ranging study of oxycodone for chronic pain in advanced cancer
20. Controlled-release oxycodone and morphine in cancer related pain
21. Randomized double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
22. Role of rectal route in treating cancer pain: A randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain
23. Rectal, buccal and sublingual narcotics for the management of cancer pain
24. Syringe drivers in palliative care: A review
25. The Edmonton injector: A simple device for patient-controlled subcutaneous analgesia
26. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy and quality of life
27. Constipation and the use of laxatives: A comparison between transdermal fentanyl and oral morphine
28. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: A preliminary report
29. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists
30. The use of nebulized opioids for breathlessness: A chart review
31. Nebulized morphine in the palliation of dypsnoea
32. Single dose randomized controlled trial of nebulised morphine in patients with cancer related breathlessness
33. Lack of effect of high doses of inhaled morphine on exercise tolerance in chronic obstructive pulmonary disease
34. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer